Entellus Completes $35 Million Financing
Minnesota-based Entellus Medical reported that it had completed a $35 million financing round led by Covidien Ventures.
Blog
Larry Birch Reveals DATATRAK’s Quarterly Results Highest Since 2008
DATATRAK [OTCQX: DATA] continues its recovery with its highest sales since 2008. Larry Birch describes the continued progress for this provider of advanced software systems for the clinical trials industry.
InVivo Therapeutics Treats the Spinal Cord Itself, A Novel Technology
Frank Reynolds, President and CEO of InVivo Therapeutics describes the company’s strategy in bringing its unique spinal cord injury (SPI) products to market.
Dr. Jun Ma Discusses Biox Monitors and Future of Cardiac Care
Vasomedical (OTC: VASO) President & CEO Jun Ma, Ph.D., was interviewed by OneMedRadio. Vasomedical is a Westbury, New York device company with a market cap of $39M focusing on cardiac disease.
January 9-12, 2012 OneMedForum San Francisco
The 5th Annual OneMedForum San Francisco 2012 is around the corner and builds on the success and recognition of four previous San Francisco Forums and two recently launched in New York City.
Keating Capital Raises $86 million to fund Pre-IPO companies.
Keating Capital’s President Timothy Keating was interviewed by OneMedRadio where he describes the liquidity premium that gives public companies 3x valuation over private company peers and the dramatic decline in IPOs and increase in size that is debilitating economic growth.
Jason Napodano Discusses ISCO’s Stem Cell Development and Recent Research Report
Zack’s Investment Research’s Senior Biotech Analyst, Jason Napodano, was interviewed by OneMedRadio where he discussed International Stem Cell Corp [OTC:ISCO].
OneMedPlace Launches OneMedRadio to Expand Coverage of Public Companies
OneMedPlace (OMP) announced the creation of OneMedRadio to anchor an expansion of coverage on small public companies in the healthcare and life sciences sector.
Roka Bioscience Raises $20 Million
Roka Bioscience revealed that it has completed a Series C round of equity financing, raising $20M.
FDA Needs To Replace Flawed 510(k) Medical Device Clearance Process
According to a report released by the Institute of Medicine (IOM) Friday, the U.S. Food and Drug Administration needs to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices.